Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites
-
Published:2024-06
Issue:4
Volume:24
Page:616-623
-
ISSN:1424-3903
-
Container-title:Pancreatology
-
language:en
-
Short-container-title:Pancreatology
Author:
Inoue KanaeORCID,
Fukushi KohORCID,
Yamaguchi Shota,
Taira TomonaoORCID,
Shibuki Taro,
Satake Tomoyuki,
Watanabe Kazuo,
Sasaki Mitsuhito,
Imaoka Hiroshi,
Mitsunaga ShuichiORCID,
Ikeda MasafumiORCID
Reference30 articles.
1. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes;McGuigan;World J Gastroenterol,2018
2. Construction and validation of a prognostic index for patients with metastatic pancreatic adenocarcinoma;Morizane;Pancreas,2011
3. Pancreatic carcinomas in a 60-year, institute-based autopsy material with special emphasis of metastatic pattern;Blastik;Pancreas,2011
4. Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study;Thomassen;Pancreas,2013
5. Pancreas adenocarcinoma: ascites, clinical manifestations, and management implications;Hicks;Clin Colorectal Cancer,2016